Fermelanta develops innovative microbial production processes for plant-based chemicals using synthetic biology. The company engineers cell factories to sustainably and scalably produce valuable molecules derived from nature. These plant secondary metabolites serve as raw materials for pharmaceuticals, cosmetics, and health foods.
Funding
$1.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
PAFounders
Product
Problem
The production of rare plant-based chemicals for pharmaceuticals, cosmetics, and health foods often relies on unsustainable and limited natural resources. Traditional extraction methods can be environmentally damaging and unable to meet the growing demand for these valuable compounds.
Solution
Fermelanta utilizes microbial fermentation and synthetic biology to create a sustainable and scalable production method for rare plant-based chemicals. The company develops optimized microbial "cell factories" capable of producing valuable plant metabolites through biosynthesis. This approach enhances the availability of these ingredients while minimizing environmental impact and reducing reliance on traditional extraction methods. By engineering microorganisms to produce these compounds, Fermelanta offers a more efficient and environmentally friendly alternative for sourcing these materials.
Target Audience
Fermelanta's primary customers are companies in the pharmaceutical, cosmetic, and health food industries seeking sustainable and scalable sources of rare plant-based chemicals.
Features
- Development of microbial cell factories for the biosynthesis of plant secondary metabolites.
- Implementation of multi-step biosynthetic pathways in host cells.
- Optimization of enzyme expression and metabolic balance through multi-omics data analysis.
- Production of raw materials for medicines, cosmetics, and health foods.
- Sustainable and scalable fermentation process.